Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioLife Solutions, Inc. (BLFS)

14.64   0.83 (6.01%) 07-02 16:45
Open: 13.67 Pre. Close: 13.81
High: 14.76 Low: 13.67
Volume: 351,360 Market Cap: 621(M)
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.79 - 14.89 14.89 - 14.98
Low: 13.44 - 13.56 13.56 - 13.67
Close: 14.45 - 14.64 14.64 - 14.82

Technical analysis

as of: 2022-07-01 4:20:28 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 19.3     One year: 22.55
Support: Support1: 14.1    Support2: 12.6
Resistance: Resistance1: 16.53    Resistance2: 19.3
Pivot: 14.22
Moving Average: MA(5): 14.51     MA(20): 14.24
MA(100): 17.75     MA(250): 32.71
MACD: MACD(12,26): 0.2     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 44.1     %D(3): 47.4
RSI: RSI(14): 52.8
52-week: High: 60.66  Low: 10.39
Average Vol(K): 3-Month: 509 (K)  10-Days: 659 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ BLFS ] has closed below upper band by 37.2%. Bollinger Bands are 40.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 30 Jun 2022
Insider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 704 Shares of Stock - MarketBeat

Thu, 30 Jun 2022
12900 Shares in BioLife Solutions, Inc. (NASDAQ:BLFS) Acquired by NorthCrest Asset Manangement LLC - Defense World

Mon, 27 Jun 2022
Billionaire Israel Englander Pulls the Trigger on These 2 “Strong Buy” Stocks - TipRanks

Sun, 19 Jun 2022
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of “Buy” by Analysts - Defense World

Thu, 09 Jun 2022
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services - PR Newswire

Wed, 08 Jun 2022
BioLife Solutions, Inc. (NASDAQ:BLFS) Expected to Post Earnings of -$0.20 Per Share - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 42 (M)
Shares Float 31 (M)
% Held by Insiders 7.2 (%)
% Held by Institutions 84.7 (%)
Shares Short 1,260 (K)
Shares Short P.Month 1,040 (K)

Stock Financials

EPS 0.12
EPS Est Next Qtl -0.06
EPS Est This Year -0.24
EPS Est Next Year -0.06
Book Value (p.s.) 11.81
Profit Margin (%) -6.5
Operating Margin (%) -23.8
Return on Assets (ttm) -4.5
Return on Equity (ttm) -2.3
Qtrly Rev. Growth 153.3
Gross Profit (p.s.) 0.91
Sales Per Share 2.86
EBITDA (p.s.) -0.38
Qtrly Earnings Growth 0
Operating Cash Flow -5 (M)
Levered Free Cash Flow -15 (M)

Stock Valuations

PE Ratio 112.61
PEG Ratio -1.6
Price to Book value 1.23
Price to Sales 5.11
Price to Cash Flow -132.85

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.